- Home
- UPBD vs BBOT Comparison
UPBD vs BBOT Comparison
Compare UPBD & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPBD | BBOT |
|---|---|---|
| Founded | 1986 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | UPBD | BBOT |
|---|---|---|
| Price | $19.81 | $12.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $32.25 | $23.83 |
| AVG Volume (30 Days) | ★ 631.5K | 272.8K |
| Earning Date | 02-19-2026 | 02-26-2026 |
| Dividend Yield | ★ 7.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.45 | N/A |
| Revenue | ★ $4,577,844,000.00 | N/A |
| Revenue This Year | $10.33 | N/A |
| Revenue Next Year | $7.55 | N/A |
| P/E Ratio | $14.11 | ★ N/A |
| Revenue Growth | ★ 7.48 | N/A |
| 52 Week Low | $15.82 | $8.50 |
| 52 Week High | $30.20 | $14.87 |
Technical Indicators
Market Signals| Indicator | UPBD | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 51.57 |
| Support Level | $19.40 | $10.08 |
| Resistance Level | $20.84 | $12.01 |
| Average True Range (ATR) | 0.74 | 1.05 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 54.62 | 48.59 |
Price Performance
Historical ComparisonAbout UPBD Upbound Group Inc.
Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.